(0.06%) 5 472.46 points
(0.06%) 39 136 points
(0.38%) 17 784 points
(-0.06%) $80.78
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.23%) $28.94
(3.61%) $1 022.00
(0.29%) $0.936
(0.68%) $10.68
(0.45%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics...
Stats | |
---|---|
今日成交量 | 200 |
平均成交量 | 12 587 |
市值 | 0.00 |
EPS | $-2.46 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0530 (18.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-08 | Tidmarsh George F | Sell | 27 771 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 1 845 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 10 957 | Common Stock |
2023-09-27 | Chawla Lakhmir S | Buy | 0 | |
2023-09-28 | Tidmarsh George F | Sell | 1 429 | Common Stock |
INSIDER POWER |
---|
-15.58 |
Last 48 transactions |
Buy: 316 523 | Sell: 2 020 596 |
音量 相关性
Revelation Biosciences, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Revelation Biosciences, 相关性 - 货币/商品
Revelation Biosciences, 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2023 |
营收: | $0 |
毛利润: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2022 |
营收: | $0 |
毛利润: | $-40 008.00 (0.00 %) |
EPS: | $-600.77 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Revelation Biosciences,
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。